Literature DB >> 12775727

Oxaliplatin for colorectal cancer in the United States: better late than never.

Ian Chau, David Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12775727     DOI： 10.1200/JCO.2003.03.074

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Drug rechallenge and treatment beyond progression--implications for drug resistance.

Authors:  Elizabeth A Kuczynski; Daniel J Sargent; Axel Grothey; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2013-09-03       Impact factor: 66.675

Review 2.  Cetuximab: in the treatment of metastatic colorectal cancer.

Authors:  Neil A Reynolds; Antona J Wagstaff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer.

Authors:  Dene Simpson; Christopher Dunn; Monique Curran; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Topical treatment with oxaliplatin for the prevention of port-site metastases in laparoscopic surgery for colorectal cancer.

Authors:  Yun-Sheng Tai; Federico Cuenca Abente; Ahmad Assalia; Kazuki Ueda; Michel Gagner
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

5.  Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.

Authors:  Issa Dahabreh; George Tsoutsos; Dimitrios Tseligas; Dimitrios Janinis
Journal:  BMC Clin Pharmacol       Date:  2006-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.